82 results
Page 2 of 5
8-K
EX-99.1
pd82s8
15 Mar 21
Ovid Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update for 2021
8:05am
8-K
g7qp5gmb0fwm5jpgw
3 Mar 21
Entry into a Material Definitive Agreement
7:05am
424B5
mhlipc0putv
20 Nov 20
Prospectus supplement for primary offering
4:23pm
8-K
EX-5.1
4mn6ne
26 Aug 20
Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock
4:10pm
8-K
EX-99.1
y3bdt2mpjh5 jse8z
26 Aug 20
Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock
4:10pm
8-K
EX-1.1
qy1co6vpam3puj1 d0
26 Aug 20
Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock
4:10pm
424B5
jsw0ll1 wdehjxhfj
26 Aug 20
Prospectus supplement for primary offering
4:07pm